su5402 Search Results


94
MedChemExpress su5402
Su5402, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/su5402/product/MedChemExpress
Average 94 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
TargetMol t6996 axitinib targetmol
T6996 Axitinib Targetmol, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/t6996 axitinib targetmol/product/TargetMol
Average 93 stars, based on 1 article reviews
t6996 axitinib targetmol - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

95
Tocris su5402
Su5402, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/su5402/product/Tocris
Average 95 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology su5402
Su5402, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/su5402/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

86
Toronto Research Chemicals su5402
Inhibition of Fgf receptor activity leads to loss of serotonergic raphe neurons. Dorsal views of tphR expression and 5HT-IR in the brains of wild-type embryos treated with 9 μM <t>SU5402</t> from 24 hpf to the stage indicated bottom left. Arrows point to serotonergic raphe neurons.
Su5402, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/su5402/product/Toronto Research Chemicals
Average 86 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier

95
Tocris fluvastatin
A zebrafish chemical screen identifies statins as regulators of craniofacial and pectoral fin tendon progenitors. (A) Design of the small-molecule screen. Wild-type embryos were incubated with individual compounds from 32 to 56 hpf and alterations in craniofacial scxa expression were assessed at 56 hpf. (B-E) Craniofacial scxa expression at 56 hpf, after incubation from 32 to 56 hpf (B,C) and at 72 hpf after incubation from 48 to 72 hpf (D,E). Atorvastatin expanded scxa expression in the pharyngeal arches (arrows) compared with controls. (F-I) Pectoral fin scxa:mcherry expression at 56 hpf (F,G) and 72 hpf (H,I) upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively. Atorvastatin expanded scxa:mcherry expression at the cleithrum base (arrowhead), extending distally to the actinotrichia. (J) qPCR quantification revealed that atorvastatin increased scxa expression at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. n=4, whole embryo (32-56 hpf) and head region (48-72 hpf); Welch's two-tailed t-test. (K) qPCR quantification revealed that <t>fluvastatin</t> increased col1a2 expression at 72 hpf, after incubation from 32 to 48 hpf compared with controls. The combination of fluvastatin, which is characterized by a shorter half-life and a shortened exposure window (Fig. S2M-R), mitigated the toxic effects observed at 72 hpf with atorvastatin treatment. n=3, head region, Welch's two-tailed t-test. (L) Atorvastatin increased the quantity of craniofacial scxa+ cells at 56 hpf and 72 hpf after incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (M) Atorvastatin increased the quantity of pectoral fin scxa:mcherry+ cells at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (N) Atorvastatin increased the quantity of col1a2+ cells at 80 hpf, after incubation from 32 to 56 hpf compared with controls. (J,K) Data are mean±s.d. (L-N) Red bars indicate mean; individual points represent values for individual embryos; Mann–Whitney-Wilcoxon test. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. Ventral (B-E) and lateral (F-I) views, anterior towards the left.
Fluvastatin, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluvastatin/product/Tocris
Average 95 stars, based on 1 article reviews
fluvastatin - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

94
Selleck Chemicals su5402
A zebrafish chemical screen identifies statins as regulators of craniofacial and pectoral fin tendon progenitors. (A) Design of the small-molecule screen. Wild-type embryos were incubated with individual compounds from 32 to 56 hpf and alterations in craniofacial scxa expression were assessed at 56 hpf. (B-E) Craniofacial scxa expression at 56 hpf, after incubation from 32 to 56 hpf (B,C) and at 72 hpf after incubation from 48 to 72 hpf (D,E). Atorvastatin expanded scxa expression in the pharyngeal arches (arrows) compared with controls. (F-I) Pectoral fin scxa:mcherry expression at 56 hpf (F,G) and 72 hpf (H,I) upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively. Atorvastatin expanded scxa:mcherry expression at the cleithrum base (arrowhead), extending distally to the actinotrichia. (J) qPCR quantification revealed that atorvastatin increased scxa expression at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. n=4, whole embryo (32-56 hpf) and head region (48-72 hpf); Welch's two-tailed t-test. (K) qPCR quantification revealed that <t>fluvastatin</t> increased col1a2 expression at 72 hpf, after incubation from 32 to 48 hpf compared with controls. The combination of fluvastatin, which is characterized by a shorter half-life and a shortened exposure window (Fig. S2M-R), mitigated the toxic effects observed at 72 hpf with atorvastatin treatment. n=3, head region, Welch's two-tailed t-test. (L) Atorvastatin increased the quantity of craniofacial scxa+ cells at 56 hpf and 72 hpf after incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (M) Atorvastatin increased the quantity of pectoral fin scxa:mcherry+ cells at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (N) Atorvastatin increased the quantity of col1a2+ cells at 80 hpf, after incubation from 32 to 56 hpf compared with controls. (J,K) Data are mean±s.d. (L-N) Red bars indicate mean; individual points represent values for individual embryos; Mann–Whitney-Wilcoxon test. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. Ventral (B-E) and lateral (F-I) views, anterior towards the left.
Su5402, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/su5402/product/Selleck Chemicals
Average 94 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

90
Sugen Inc tyrosine kinase inhibitor su5402
A zebrafish chemical screen identifies statins as regulators of craniofacial and pectoral fin tendon progenitors. (A) Design of the small-molecule screen. Wild-type embryos were incubated with individual compounds from 32 to 56 hpf and alterations in craniofacial scxa expression were assessed at 56 hpf. (B-E) Craniofacial scxa expression at 56 hpf, after incubation from 32 to 56 hpf (B,C) and at 72 hpf after incubation from 48 to 72 hpf (D,E). Atorvastatin expanded scxa expression in the pharyngeal arches (arrows) compared with controls. (F-I) Pectoral fin scxa:mcherry expression at 56 hpf (F,G) and 72 hpf (H,I) upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively. Atorvastatin expanded scxa:mcherry expression at the cleithrum base (arrowhead), extending distally to the actinotrichia. (J) qPCR quantification revealed that atorvastatin increased scxa expression at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. n=4, whole embryo (32-56 hpf) and head region (48-72 hpf); Welch's two-tailed t-test. (K) qPCR quantification revealed that <t>fluvastatin</t> increased col1a2 expression at 72 hpf, after incubation from 32 to 48 hpf compared with controls. The combination of fluvastatin, which is characterized by a shorter half-life and a shortened exposure window (Fig. S2M-R), mitigated the toxic effects observed at 72 hpf with atorvastatin treatment. n=3, head region, Welch's two-tailed t-test. (L) Atorvastatin increased the quantity of craniofacial scxa+ cells at 56 hpf and 72 hpf after incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (M) Atorvastatin increased the quantity of pectoral fin scxa:mcherry+ cells at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (N) Atorvastatin increased the quantity of col1a2+ cells at 80 hpf, after incubation from 32 to 56 hpf compared with controls. (J,K) Data are mean±s.d. (L-N) Red bars indicate mean; individual points represent values for individual embryos; Mann–Whitney-Wilcoxon test. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. Ventral (B-E) and lateral (F-I) views, anterior towards the left.
Tyrosine Kinase Inhibitor Su5402, supplied by Sugen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tyrosine kinase inhibitor su5402/product/Sugen Inc
Average 90 stars, based on 1 article reviews
tyrosine kinase inhibitor su5402 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Merck KGaA vegf inhibitor su5416
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Vegf Inhibitor Su5416, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vegf inhibitor su5416/product/Merck KGaA
Average 90 stars, based on 1 article reviews
vegf inhibitor su5416 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc su5402
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Su5402, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/su5402/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
FUJIFILM su5402
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Su5402, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/su5402/product/FUJIFILM
Average 90 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Pfizer Inc su5402
Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.
Su5402, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/su5402/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
su5402 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Inhibition of Fgf receptor activity leads to loss of serotonergic raphe neurons. Dorsal views of tphR expression and 5HT-IR in the brains of wild-type embryos treated with 9 μM SU5402 from 24 hpf to the stage indicated bottom left. Arrows point to serotonergic raphe neurons.

Journal: Journal of neurobiology

Article Title: Hedgehog and Fgf Signaling Pathways Regulate the Development of tphR -Expressing Serotonergic Raphe Neurons in Zebrafish Embryos

doi: 10.1002/neu.20023

Figure Lengend Snippet: Inhibition of Fgf receptor activity leads to loss of serotonergic raphe neurons. Dorsal views of tphR expression and 5HT-IR in the brains of wild-type embryos treated with 9 μM SU5402 from 24 hpf to the stage indicated bottom left. Arrows point to serotonergic raphe neurons.

Article Snippet: SU5402 and Cyclopamine Treatment Dechorionated 24 h postfertilization (hpf) embryos were incubated in the dark in 9 μM SU5402 (Calbiochem) or 100 μM cyclopamine (Toronto Research Chemicals) until 48 hpf for in situ hybridization and 60 hpf for 5HT antibody staining.

Techniques: Inhibition, Activity Assay, Expressing

A zebrafish chemical screen identifies statins as regulators of craniofacial and pectoral fin tendon progenitors. (A) Design of the small-molecule screen. Wild-type embryos were incubated with individual compounds from 32 to 56 hpf and alterations in craniofacial scxa expression were assessed at 56 hpf. (B-E) Craniofacial scxa expression at 56 hpf, after incubation from 32 to 56 hpf (B,C) and at 72 hpf after incubation from 48 to 72 hpf (D,E). Atorvastatin expanded scxa expression in the pharyngeal arches (arrows) compared with controls. (F-I) Pectoral fin scxa:mcherry expression at 56 hpf (F,G) and 72 hpf (H,I) upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively. Atorvastatin expanded scxa:mcherry expression at the cleithrum base (arrowhead), extending distally to the actinotrichia. (J) qPCR quantification revealed that atorvastatin increased scxa expression at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. n=4, whole embryo (32-56 hpf) and head region (48-72 hpf); Welch's two-tailed t-test. (K) qPCR quantification revealed that fluvastatin increased col1a2 expression at 72 hpf, after incubation from 32 to 48 hpf compared with controls. The combination of fluvastatin, which is characterized by a shorter half-life and a shortened exposure window (Fig. S2M-R), mitigated the toxic effects observed at 72 hpf with atorvastatin treatment. n=3, head region, Welch's two-tailed t-test. (L) Atorvastatin increased the quantity of craniofacial scxa+ cells at 56 hpf and 72 hpf after incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (M) Atorvastatin increased the quantity of pectoral fin scxa:mcherry+ cells at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (N) Atorvastatin increased the quantity of col1a2+ cells at 80 hpf, after incubation from 32 to 56 hpf compared with controls. (J,K) Data are mean±s.d. (L-N) Red bars indicate mean; individual points represent values for individual embryos; Mann–Whitney-Wilcoxon test. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. Ventral (B-E) and lateral (F-I) views, anterior towards the left.

Journal: Development (Cambridge, England)

Article Title: The mevalonate pathway is a crucial regulator of tendon cell specification

doi: 10.1242/dev.185389

Figure Lengend Snippet: A zebrafish chemical screen identifies statins as regulators of craniofacial and pectoral fin tendon progenitors. (A) Design of the small-molecule screen. Wild-type embryos were incubated with individual compounds from 32 to 56 hpf and alterations in craniofacial scxa expression were assessed at 56 hpf. (B-E) Craniofacial scxa expression at 56 hpf, after incubation from 32 to 56 hpf (B,C) and at 72 hpf after incubation from 48 to 72 hpf (D,E). Atorvastatin expanded scxa expression in the pharyngeal arches (arrows) compared with controls. (F-I) Pectoral fin scxa:mcherry expression at 56 hpf (F,G) and 72 hpf (H,I) upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively. Atorvastatin expanded scxa:mcherry expression at the cleithrum base (arrowhead), extending distally to the actinotrichia. (J) qPCR quantification revealed that atorvastatin increased scxa expression at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. n=4, whole embryo (32-56 hpf) and head region (48-72 hpf); Welch's two-tailed t-test. (K) qPCR quantification revealed that fluvastatin increased col1a2 expression at 72 hpf, after incubation from 32 to 48 hpf compared with controls. The combination of fluvastatin, which is characterized by a shorter half-life and a shortened exposure window (Fig. S2M-R), mitigated the toxic effects observed at 72 hpf with atorvastatin treatment. n=3, head region, Welch's two-tailed t-test. (L) Atorvastatin increased the quantity of craniofacial scxa+ cells at 56 hpf and 72 hpf after incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (M) Atorvastatin increased the quantity of pectoral fin scxa:mcherry+ cells at 56 hpf and 72 hpf upon incubation from 32 to 56 hpf and 48 to 72 hpf, respectively, compared with controls. (N) Atorvastatin increased the quantity of col1a2+ cells at 80 hpf, after incubation from 32 to 56 hpf compared with controls. (J,K) Data are mean±s.d. (L-N) Red bars indicate mean; individual points represent values for individual embryos; Mann–Whitney-Wilcoxon test. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001. Ventral (B-E) and lateral (F-I) views, anterior towards the left.

Article Snippet: Embryos were incubated in the following compounds: atorvastatin, lovastatin, fluvastatin, FTI-277 and SU5402 (Tocris Bioscience); simvastatin, aphidicolin and GGTI-286 (Sigma-Aldrich); and RO48-8071, EHT-1864, ML-141, Y-27632 and SB-431542 (Cayman Chemical).

Techniques: Incubation, Expressing, Two Tailed Test, MANN-WHITNEY

Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods,  and  ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.

Journal: Current Issues in Molecular Biology

Article Title: Pro-Angiogenetic Effects of Purified Extracts from Helix aspersa during Zebrafish Development

doi: 10.3390/cimb44080232

Figure Lengend Snippet: Pretreatment with a VEGF pathway inhibitor prevented the formation of intersomitic vessels: The panels show representative images of a WISH assay performed with fli1 as an endothelial marker, at 36 hpf, in untreated ( A , C , E , G , I ) and treated embryos ( B , D , F , H , J ) with SUGEN 5416. Previously, some embryos were treated with snail derivatives via Method I and controls with fish water and 0.1% DMSO (see Materials and Methods, and ). Magnification of the trunk region (32×). Two replicates were performed ( n = 15). Ratios at the bottom-left part of each picture specify the number of embryos showing the same staining pattern, compared to the total number of embryos used for each experiment. The images were taken in lateral position at 32× magnification with a Zeiss Axiozoom V13 (Zeiss, Jena, Germany) microscope, equipped with a PlanNeoFluar Z 1×/0.25 FWD 56 mm lens and Zen Pro software.

Article Snippet: Zebrafish embryos were then treated at 4 hpf with the snail derivatives LH, LM, LH3, and LM2, and then at 15 hpf with the VEGF inhibitor SU5416 (Sunitinib, Merck KGaA, Darmstadt, Germany) at a final concentration of 5 μg/mL in fish water and incubated in 3 cm diameter well-plates.

Techniques: Marker, Staining, Microscopy, Software